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LITERATURE REVIEW
phlebotomy and processing time can lead to false 
elevations or spurious results4-6. The sensitivity and 
specificity of a venous ammonia greater than 55 
µmol/L) to diagnose HE were 47.2% and 78.4%, 
respectively. In one study, 60% of the patients with 
grade 3 HE by the West Haven Criteria had a normal 
serum ammonia level7. These test characteristics 
underlie the AASLD recommendation to avoid checking 
serum ammonia in patients with chronic liver disease 
to diagnose or assess the severity of HE. Covert HE (i.e. 
Grade I HE by WHC) remains a diagnostic challenge 
given the lack of reproducibility of clinical findings, but 
trivial lack of awareness, shortened attention span, and 
altered sleep rhythm can raise suspicion for this 
diagnosis in patients with liver disease.
Institutional ordering characteristics and associated 
healthcare charges for serum ammonia
Between the initial date of data recording (11/25/2016) to 
the day the database was accessed (1/14/2020), there 
were a total of 7541 serum ammonia orders. Of these 
orders, 6206 orders occurred in the inpatient setting, 
with a charge of $201 per order according to the publicly 
available institutional chargemaster8 (Figure 1). Note that 
these charges do not reflect what the patient pays; 
insurance companies dictate how much reimbursement 
the institution receives. The average dollar amount of 
charges per month attributable to inpatient serum 
ammonia orders alone is $31,984.76, calculated by 
dividing the total charge amount for all serum ammonia 
orders over the examined time ($1,247,406) by the 
number of months of data (39 months). The departments 
who ordered the most serum ammonia levels are 
Medicine (2404 orders total), Emergency Medicine in the 
flagship hospital (1702), and Emergency Medicine in a 
nearby community hospital (702) (Figure 2).
Serum Folate Levels in the Assessment  
of Anemia
Folic acid (folate) is a critical water-soluble B vitamin 
used in the process of DNA synthesis. Deficiency of 
folate manifests in newborns as neural tube defects 
and classically as macrocytic, megaloblastic anemia in 
adults. In an effort to reduce the incidence of neural 
tube defects, the US government began mandating 
supplementation of every 1 gram of grain with 140 mcg 
High value care encompasses a variety of principles 
including ordering tests with high diagnostic yield, while 
reducing low value practices. Two tests that are 
frequently ordered but rarely contribute meaningfully to 
the diagnosis and management of patients are serum 
ammonia levels and serum folate levels. The American 
Association for the Study of Liver Disease (AASLD) 
recommends against using blood ammonia levels for 
hepatic encephalopathy (HE), stating that the test does 
not add “any diagnostic, staging, or prognostic value” 
for patients with chronic liver disease1. The American 
Society for Clinical Pathology (ASCP) in the Choosing 
Wisely campaign by the American Board of Internal 
Medicine recommended considering “folate supple-
mentation instead of serum folate testing in patients 
with macrocytic anemia2.” In the following discussion, 
we will discuss the evidence behind these claims in 
addition to our own argument against routinely ordering 
serum ammonia and serum folate levels in the 
assessment of hepatic encephalopathy and anemia, 
respectively. We will also provide a preliminary analysis 
of the cost related to these tests and the potential 
impact of changing ordering practices at our institution, 
a large urban academic medical system.
Serum Ammonia Levels in the Assessment 
of Hepatic Encephalopathy
HE is a brain dysfunction caused by liver pathology, 
portosystemic shunting, or both. It manifests in a wide 
spectrum of neurological and psychiatric abnormalities 
and is typically a clinical diagnosis using the West Haven 
Criteria (WHC) classification system1. Because 85% of 
ammonia is detoxified by the liver and excreted as urea 
in urine (with muscle and brain tissue metabolizing the 
rest), it has been theorized that hyperammonemia 
contributes to HE3. Astrocytes synthesize more 
glutamine in the setting of increased ammonia, 
precipitating reactive oxygen species, astrocyte 
swelling, and enhanced gamma-aminobutryic acid 
(GABA) inhibition, manifesting as cerebral dysfunction. 
In addition, bleeding, infection, and renal failure all 
precipitate HE and incidentally promote hyperam-
monemia. With these underlying factors in mind, it 
would appear that ammonia levels would be helpful in 
the diagnosis of HE. Multiple issues with serum 
ammonia, however, limit its usefulness. Fist clenching, 
the use of a tourniquet during the process of 
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of folic acid in 1996, leading to a 36% reduction in the 
prevalence of neural tube defects in the US.9 This 
fortification has led to a significant decline in prevalence 
of adult folate deficiency. In an analysis of the National 
Health and Nutrition Examination Survey (NHANES) 
study group, Pfeiffer and colleagues found that “the 
percentage of the population with low serum folate (<3 
ng/mL) declined from 21% in the period before 
fortification (1988--1994) to <1% of the total population 
in the period immediately following fortification10 
(1999--2000)." Despite low prevalence of folate 
deficiency clinicians continue to order the assay, which 
has its own innate flaws. Although the microbiologic 
assay for serum folate is more accurate and the gold 
standard, the competitive protein binding assay is more 
frequently used due to its relative technical ease. 
Unfortunately this protein binding assay has a coefficient 
of variance between samples from the same individuals 
of 21.5%11. Finally, the cost of treatment of folate 
deficiency is orders of magnitude less expensive than 
the assay itself: 400 mcg folate tablets range from $0.03 
per tablet to $0.20 cents per tablet, while the charge for 
the folate assay ranges from $25 in outpatient assistance 
programs from commercial laboratory corporations to 
$207 by the institutional chargemaster8, 12 (Serum folate 
assay pricing, LabCorp© and Quest Diagnostics 
Customer Service, phone call, 1/14/2020). Thus, when 
a macrocytic anemia and the suspicion for an isolated 
folate deficiency is high (malabsorptive issues, prior GI 
surgery, prolonged malnutrition), it is reasonable to 
initiate folate supplementation and to recheck a 
complete blood count in 4 weeks to see if the MCV and 
anemia has changed13. 
Institutional ordering characteristics and associated 
healthcare charges for serum folate
With the same criteria as the prior analysis, there were 
43,932 total serum folate and combined serum folate 
and vitamin B12 orders. Of these orders, 7193 were 
serum folate alone. The Department of Medicine ordered 
33,451 (76.1%) of the total orders (Figure 3). The total 
charge per month for serum folate orders was estimated 
to be between $28,161.53 and $233,177.53 using the $25 
charge from commercial laboratory and the $207 charge 
from the institutional chargemaster to generate the 
range. Note that the $25 charge is a direct cost to the 
patient, while the $207 is the charge submitted to 
insurance companies.
CONCLUSION 
Serum ammonia and serum folate levels should not be 
routinely ordered in the diagnosis and management of 
hepatic encephalopathy or in the diagnosis of anemia, 
respectively. Chargemaster charges and simple numerical 
counts of orders shows a significant charge burden for 
tests that do not significantly impact patient care. While 
this analysis does not provide cost estimates to the 
institution as a whole as it does not incorporate assay 
costs and lab personnel processing time, it reveals the 
charges that minimal utility tests impose on the healthcare 
system. One proposal to reduce ordering folate levels is 
to replace the combined folate/B12 order with individual 
folate and B12 orders in physician preference lists. Future 
work will assess the impact of iterative changes on the 
reduction of these orders and strive to understand the 
cost of these assays to the institution.
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